A Study of V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)

Clinical trial NCT01073293 · COMPLETED

Trial details

NCT number: NCT01073293
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Papillomavirus Infections

Start date: 2010-04-22
Primary completion: 2011-06-16
Enrollment: 1054

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.